Marshall Wace, LLP Instil Bio, Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.63 $161,333 - $254,100	-403,334 Reduced 24.96%	1,212,524 $521,000
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $940,695 - $2.49 Million	223,443 Added 16.05%	1,615,858 $7.47 Million
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $18.6 Million - $27.3 Million	1,212,524 Added 674.03%	1,392,415 $23.8 Million
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $4.36 Million - $4.87 Million	179,891 New	179,891 $4.51 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.39B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.